174 related articles for article (PubMed ID: 32163836)
41. Metabolic characterization of tumor cell-specific protoporphyrin IX accumulation after exposure to 5-aminolevulinic acid in human colonic cells.
Krieg RC; Messmann H; Rauch J; Seeger S; Knuechel R
Photochem Photobiol; 2002 Nov; 76(5):518-25. PubMed ID: 12462647
[TBL] [Abstract][Full Text] [Related]
42. Cell-type specific protoporphyrin IX metabolism in human bladder cancer in vitro.
Krieg RC; Fickweiler S; Wolfbeis OS; Knuechel R
Photochem Photobiol; 2000 Aug; 72(2):226-33. PubMed ID: 10946577
[TBL] [Abstract][Full Text] [Related]
43. The influence of iron chelators on the accumulation of protoporphyrin IX in 5-aminolaevulinic acid-treated cells.
Berg K; Anholt H; Bech O; Moan J
Br J Cancer; 1996 Sep; 74(5):688-97. PubMed ID: 8795569
[TBL] [Abstract][Full Text] [Related]
44. Regulation of 5-aminolevulinic acid-dependent protoporphyrin IX accumulations in human histiocytic lymphoma U937 cells.
Okimura Y; Fujita H; Ogino T; Inoue K; Shuin T; Yano H; Yasuda T; Inoue M; Utsumi K; Sasaki J
Physiol Chem Phys Med NMR; 2007; 39(1):69-82. PubMed ID: 18613640
[TBL] [Abstract][Full Text] [Related]
45. Identification of PEPT2 as an important candidate molecule in 5-ALA-mediated fluorescence-guided surgery in WHO grade II/III gliomas.
Hou C; Yamaguchi S; Ishi Y; Terasaka S; Kobayashi H; Motegi H; Hatanaka KC; Houkin K
J Neurooncol; 2019 Jun; 143(2):197-206. PubMed ID: 30929128
[TBL] [Abstract][Full Text] [Related]
46. Preclinical characterization of 5-amino-4-oxo-[6-11C]hexanoic acid as an imaging probe to estimate protoporphyrin IX accumulation induced by exogenous aminolevulinic acid.
Suzuki C; Tsuji AB; Kato K; Kikuchi T; Sudo H; Okada M; Sugyo A; Zhang MR; Arano Y; Saga T
J Nucl Med; 2014 Oct; 55(10):1671-7. PubMed ID: 25125482
[TBL] [Abstract][Full Text] [Related]
47. Red-light excitation of protoporphyrin IX fluorescence for subsurface tumor detection.
Roberts DW; Olson JD; Evans LT; Kolste KK; Kanick SC; Fan X; Bravo JJ; Wilson BC; Leblond F; Marois M; Paulsen KD
J Neurosurg; 2018 Jun; 128(6):1690-1697. PubMed ID: 28777025
[TBL] [Abstract][Full Text] [Related]
48. Her2 oncogene transformation enhances 5-aminolevulinic acid-mediated protoporphyrin IX production and photodynamic therapy response.
Yang X; Palasuberniam P; Myers KA; Wang C; Chen B
Oncotarget; 2016 Sep; 7(36):57798-57810. PubMed ID: 27527860
[TBL] [Abstract][Full Text] [Related]
49. The inhibition of ferrochelatase enhances 5-aminolevulinic acid-based photodynamic action for prostate cancer.
Fukuhara H; Inoue K; Kurabayashi A; Furihata M; Fujita H; Utsumi K; Sasaki J; Shuin T
Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):399-409. PubMed ID: 24284092
[TBL] [Abstract][Full Text] [Related]
50. Molecular and Metabolic Mechanisms Underlying Selective 5-Aminolevulinic Acid-Induced Fluorescence in Gliomas.
Traylor JI; Pernik MN; Sternisha AC; McBrayer SK; Abdullah KG
Cancers (Basel); 2021 Feb; 13(3):. PubMed ID: 33540759
[TBL] [Abstract][Full Text] [Related]
51. Experimental study to understand nonspecific protoporphyrin IX fluorescence in brain tissues near tumors after 5-aminolevulinic acid administration.
Masubuchi T; Kajimoto Y; Kawabata S; Nonoguchi N; Fujishiro T; Miyatake S; Kuroiwa T
Photomed Laser Surg; 2013 Sep; 31(9):428-33. PubMed ID: 23869519
[TBL] [Abstract][Full Text] [Related]
52. Calcitriol enhances 5-aminolevulinic acid-induced fluorescence and the effect of photodynamic therapy in human glioma.
Chen X; Wang C; Teng L; Liu Y; Chen X; Yang G; Wang L; Liu H; Liu Z; Zhang D; Zhang Y; Guan H; Li X; Fu C; Zhao B; Yin F; Zhao S
Acta Oncol; 2014 Mar; 53(3):405-13. PubMed ID: 24032442
[TBL] [Abstract][Full Text] [Related]
53. Deferoxamine iron chelation increases delta-aminolevulinic acid induced protoporphyrin IX in xenograft glioma model.
Valdés PA; Samkoe K; O'Hara JA; Roberts DW; Paulsen KD; Pogue BW
Photochem Photobiol; 2010; 86(2):471-5. PubMed ID: 20003159
[TBL] [Abstract][Full Text] [Related]
54. Complementary Molecular and Elemental Mass-Spectrometric Imaging of Human Brain Tumors Resected by Fluorescence-Guided Surgery.
Kröger S; Niehoff AC; Jeibmann A; Sperling M; Paulus W; Stummer W; Karst U
Anal Chem; 2018 Oct; 90(20):12253-12260. PubMed ID: 30215510
[TBL] [Abstract][Full Text] [Related]
55. Low-dose arsenic trioxide enhances 5-aminolevulinic acid-induced PpIX accumulation and efficacy of photodynamic therapy in human glioma.
Wang C; Chen X; Wu J; Liu H; Ji Z; Shi H; Gao C; Han D; Wang L; Liu Y; Yang G; Fu C; Li H; Zhang D; Liu Z; Li X; Yin F; Zhao S
J Photochem Photobiol B; 2013 Oct; 127():61-7. PubMed ID: 23962849
[TBL] [Abstract][Full Text] [Related]
56. On the role of iron and one of its chelating agents in the production of protoporphyrin IX generated by 5-aminolevulinic acid and its hexyl ester derivative tested on an epidermal equivalent of human skin.
Uehlinger P; Ballini JP; van den Bergh H; Wagnières G
Photochem Photobiol; 2006; 82(4):1069-76. PubMed ID: 17205631
[TBL] [Abstract][Full Text] [Related]
57. Roles of the ABCG2 transporter in protoporphyrin IX distribution and toxicity.
Qi Q; Gu R; Zhu J; Anderson KE; Ma X
Drug Metab Dispos; 2024 Feb; ():. PubMed ID: 38351044
[TBL] [Abstract][Full Text] [Related]
58. Protoporphyrin IX fluorescence kinetics in C6 glioblastoma cells after delta-aminolevulinic acid incubation: effect of a protoporphyrinogen oxidase inhibitor.
Carre J; Eleouet S; Rousset N; Vonarx V; Heyman D; Lajat Y; Patrice T
Cell Mol Biol (Noisy-le-grand); 1999 Jun; 45(4):433-44. PubMed ID: 10432190
[TBL] [Abstract][Full Text] [Related]
59. Protoporphyrin IX fluorescence and photobleaching during interstitial photodynamic therapy of malignant gliomas for early treatment prognosis.
Johansson A; Faber F; Kniebühler G; Stepp H; Sroka R; Egensperger R; Beyer W; Kreth FW
Lasers Surg Med; 2013 Apr; 45(4):225-34. PubMed ID: 23533060
[TBL] [Abstract][Full Text] [Related]
60. Dual-labeling with 5-aminolevulinic acid and fluorescein for fluorescence-guided resection of high-grade gliomas: technical note.
Suero Molina E; Wölfer J; Ewelt C; Ehrhardt A; Brokinkel B; Stummer W
J Neurosurg; 2018 Feb; 128(2):399-405. PubMed ID: 28338432
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
